Venous Therapies

This channel includes news and new technology innovations of Venous Therapies including deep vein thrombosis (DVT) and vena cava filters.

The Bluegrass Vascular Surfacer System is designed to reliably, efficiently and repeatedly gain central venous access by inserting the Surfacer System through the right femoral vein and navigating it up through the patient’s venous system with an exit point in the right internal jugular vein, the optimal location for placing a central venous catheter.

News | EP Lab

Case Report on CRT Lead Placement in Obstructed Veins Using Surfacer System

May 6, 2021 - Bluegrass Vascular Technologies announced the publication of a report documenting the clinical utility of ...

May 06, 2021

Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) can potentiate all 3 sides of Virchow’s Triad of coagulopathy, including endothelial dysfunction, blood flow stasis, and hypercoagulability. Angiotensin-converting enzyme-2 (ACE-2)–dependent viral entry and the virus-induced inflammatory response can lead to endothelial dysfunction. Clotting Prevention in COVID-19 Patients, Thrombosis Prevention in COVID-19 Patients, Preventing blood clots in COVID-19 patients

Feature | Antiplatelet and Anticoagulation Therapies | By Dave Fornell, Editor

Overview of Trials for Anticoagulation Therapy for COVID-19 Patients

A comprehensive review or more than 80 randomized controlled trials (RCTs) investigating how to best manage optimal ...

March 22, 2021

News | Venous Therapies

FDA Clears Zilver Vena Venous Self-Expanding Stent

February 22, 2021 — The U.S. Food and Drug Administration (FDA) recently cleared the Cook Medical Zilver Vena Venous ...

February 22, 2021

Abre venous self-expanding stent found safe, effective in treating challenging deep venous lesions was approved by the FDA.

News | Venous Therapies

Medtronic Venous Stent Receives U.S. FDA Approval to Treat Venous Outflow Obstruction

October 26, 2020 — The U.S. Food and Drug Administration (FDA) has cleared the Medtronic Abre venous self-expanding ...

October 26, 2020

IVC filter guidelines. The Society of Interventional Radiology (SIR) published new inferior vena cava (IVC) filter guidelines.

News | Vena Cava Filters

Society of Interventional Radiology Publishes IVC Filter Guidelines

September 9, 2020 — The Society of Interventional Radiology (SIR) published new clinical practice guidelines that ...

September 09, 2020

News | Atherectomy Devices

BD Acquires Atherectomy and Thrombectomy Technologies With Straub Medical

July 20, 2020 – BD (Becton, Dickinson and Company) recently completed the acquisition of Straub Medical AG, a privately ...

July 20, 2020

A comparison of intravascular ultrasound (IVUS) vs. angiography found a significant mismatch and showed the benefits of IVUS in venous interventions.

News | Venous Therapies

IVUS Better Than Venography to Identify Venous Stent Landing Zones

October 31, 2019 – In a large series of iliac vein stent cases, a blinded comparison found intravascular ultrasound ...

October 31, 2019

News | Electronic Medical Records (EMR)

New Study Visually Tracks Chronic Venous Insufficiency Wound Healing in EMR

August 13, 2019 — A simple change in the way health professionals track their patients’ progress has brought improved ...

August 13, 2019

Fragmin (dalteparin sodium) injection was cleared by the FDA for use in pediatric patients. It was initially approved by the FDA in 1994 for adults and is a type of heparin.

Technology | Antiplatelet and Anticoagulation Therapies

FDA Clears First Anticoagulant for Pediatric Patients With VTE or PE

May 17, 2019 — The U.S. Food and Drug Administration (FDA) this week approved Fragmin (dalteparin sodium) injection, for ...

May 17, 2019

Illustration showing the self-expanding deployment of the Boston Scientific Vici venous stent in the iliofemoral vein.

Technology | Venous Therapies

FDA Clears Boston Scientific Vici Venous Stent to Treat Deep Venous Blockages

May 6, 2019 — The U.S Food and Drug Administration (FDA) has cleared the Boston Scientific Vici Venous Stent System for ...

May 06, 2019

The U.S. Food and Drug Administration (FDA) recently cleared Bard Peripheral Vascular's Venovo Venous Stent System intended to treat narrowed iliofemoral veins.

Technology | Venous Therapies

FDA Clears Venous Stent for the Iliofemoral Veins

April 3, 2019 — The U.S. Food and Drug Administration (FDA) recently cleared Bard Peripheral Vascular's Venovo Venous ...

April 03, 2019

News | Thrombectomy Devices

JETi Thrombectomy System Safe and Effective for Deep Vein Thrombosis

February 12, 2019 — A study presented at the 2018 annual meeting of the Cardiovascular and Interventional Radiology ...

February 12, 2019

An assortment of Boston Scientific AngioJet rheolytic thrombectomy catheters. These devices use high-velocity saline jets to entrain thrombus, resulting in microfragmentation and removal. Thrombectomy is also referred to as embolectomy.

Feature | Thrombectomy Devices | Dave Fornell, Editor

Advances in Thrombectomy Technologies in a Post-coronary Era

Catheter-based blood clot removal a decade ago was a standard of care for acute coronary revascularization, but declined ...

January 22, 2019

News | Venous Therapies

Boston Scientific to Acquire Veniti Inc.

August 8, 2018 — Boston Scientific Corp. announced it has signed an agreement to acquire Veniti Inc., which has ...

August 08, 2018

A patient case study showing a venous ulcer formation 18 months following thermal ablation varicose vein treatment in the GSV. The patient was treated with Varithena polidocanol endovenous microfoam chemical-ablation. Images show baseline prior to treatment (right), followed by one, four and six weeks after treatment. The treatment is also called sclerotherapy.

Feature | Venous Therapies | Tif Siragusa, M.D.

Treatment of Recurrent Varicose Veins With Chemical Ablation

The introduction of thermal ablation revolutionized the treatment of varicose veins, yet recurrence remains a stubborn ...

April 30, 2018